1. Home
  2. FGBI vs CRBP Comparison

FGBI vs CRBP Comparison

Compare FGBI & CRBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FGBI
  • CRBP
  • Stock Information
  • Founded
  • FGBI 1934
  • CRBP 2009
  • Country
  • FGBI United States
  • CRBP United States
  • Employees
  • FGBI N/A
  • CRBP N/A
  • Industry
  • FGBI Savings Institutions
  • CRBP Biotechnology: Pharmaceutical Preparations
  • Sector
  • FGBI Finance
  • CRBP Health Care
  • Exchange
  • FGBI Nasdaq
  • CRBP Nasdaq
  • Market Cap
  • FGBI 121.5M
  • CRBP 110.3M
  • IPO Year
  • FGBI N/A
  • CRBP N/A
  • Fundamental
  • Price
  • FGBI $7.84
  • CRBP $9.79
  • Analyst Decision
  • FGBI
  • CRBP Strong Buy
  • Analyst Count
  • FGBI 0
  • CRBP 10
  • Target Price
  • FGBI N/A
  • CRBP $53.22
  • AVG Volume (30 Days)
  • FGBI 3.6K
  • CRBP 107.9K
  • Earning Date
  • FGBI 08-18-2025
  • CRBP 08-05-2025
  • Dividend Yield
  • FGBI 0.50%
  • CRBP N/A
  • EPS Growth
  • FGBI N/A
  • CRBP N/A
  • EPS
  • FGBI N/A
  • CRBP N/A
  • Revenue
  • FGBI $59,070,000.00
  • CRBP N/A
  • Revenue This Year
  • FGBI N/A
  • CRBP N/A
  • Revenue Next Year
  • FGBI $3.38
  • CRBP $270.04
  • P/E Ratio
  • FGBI N/A
  • CRBP N/A
  • Revenue Growth
  • FGBI N/A
  • CRBP N/A
  • 52 Week Low
  • FGBI $6.56
  • CRBP $4.64
  • 52 Week High
  • FGBI $15.25
  • CRBP $61.89
  • Technical
  • Relative Strength Index (RSI)
  • FGBI 40.14
  • CRBP 62.32
  • Support Level
  • FGBI $7.70
  • CRBP $8.88
  • Resistance Level
  • FGBI $8.08
  • CRBP $9.59
  • Average True Range (ATR)
  • FGBI 0.19
  • CRBP 0.59
  • MACD
  • FGBI -0.03
  • CRBP 0.03
  • Stochastic Oscillator
  • FGBI 19.67
  • CRBP 78.45

About FGBI First Guaranty Bancshares Inc.

First Guaranty Bancshares Inc provides personalized commercial banking services to its customers in Louisiana, through several banking facilities. The principal business activity of the company includes attracting deposits and investing it together with funds generated from operations and borrowings insecurities and in lending activities to serve the credit needs of its customer base. The company offers commercial real estate loans, commercial and industrial loans, construction and land development loans, agricultural and farmland loans, and to a lesser extent, consumer and multifamily loans.

About CRBP Corbus Pharmaceuticals Holdings Inc.

Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.

Share on Social Networks: